What is ibogaine?

Evidence level: C Emerging evidence — observational studies and case series, no randomised controlled trials yet. We say so wherever it matters.

Ibogaine is a naturally occurring psychoactive alkaloid found in the root bark of the West African shrub Tabernanthe iboga. In medicine it is used for one specific purpose: a single, physician-supervised session that interrupts opioid withdrawal and sharply reduces drug cravings, opening a window in which psychological recovery work becomes possible.

It is not a recreational drug, not a daily medication, and not a cure on its own. It is also not risk-free — which is why the setting in which it is given matters more than almost anything else about it. This guide explains what ibogaine actually is, how it works, what it is used for, and what a responsible treatment looks like.

Where ibogaine comes from

Ibogaine is one of a dozen alkaloids present in the root bark of Tabernanthe iboga, a shrub native to Gabon, Cameroon and other parts of West Central Africa. It is also extracted from Voacanga africana, a more abundant tree that has become the main commercial source for most ibogaine used in clinics today.

In its traditional context, iboga is a sacred plant of the Bwiti religion, taken in initiation ceremonies that mark the passage into adulthood. Western medicine encountered its anti-addictive effect much later, and by a different route entirely — see What is iboga → for the plant, the tradition and the difference between the two terms.

How ibogaine was discovered as an addiction treatment

In 1962 an American named Howard Lotsof, then dependent on heroin, took ibogaine expecting a powerful psychoactive experience. What he reported instead became the foundation of the entire field: within about 24 hours he was no longer in withdrawal and no longer experiencing cravings. That observation — that a single dose could interrupt dependence rather than manage it — is what pulled ibogaine out of ethnobotany and into addiction medicine.

How ibogaine works in the body

Ibogaine itself is not the main active agent for long. After it is taken, the liver converts it into noribogaine, a long-acting metabolite; both cross into the brain, where ibogaine binds to a wide range of receptor systems — including opioid receptors. This is the mechanism behind its most striking clinical effect: when ibogaine occupies those receptors, opioid withdrawal stops, often within the first hour or two of a session.

Because that conversion has to happen first, effects do not begin immediately. Onset is typically around an hour after dosing.

Two features distinguish ibogaine from conventional addiction medications. It is not taken daily — methadone and buprenorphine are maintenance drugs that manage dependence indefinitely, while ibogaine is given as a single supervised session. And its effect is twofold: the physical relief of withdrawal and craving, and a prolonged introspective state that patients and clinicians describe as making psychological work unusually accessible.

How ibogaine works →

What ibogaine is used for

Clinically, ibogaine is used for substance dependence. Its best-documented application is opioid dependence — heroin, fentanyl, prescription painkillers, and transitions off methadone or buprenorphine — because withdrawal interruption is its most reliable and immediate effect.

It is also widely used for stimulant dependence. In Brazil, where Dr. Bruno Rasmussen has run a hospital-based ibogaine program since 1994, the majority of patients are dependent on cocaine or crack cocaine rather than opioids. Alcohol dependence is a third common indication.

Beyond addiction, ibogaine is being studied for trauma, PTSD and treatment-resistant depression. Here the evidence base is younger and thinner, and any honest account should say so.

What ibogaine is not used for is maintenance. It does not replace a daily drug with another daily drug, and it is not administered repeatedly as a routine.

Ibogaine for opioid addiction → · Ibogaine for alcohol →

What happens during an ibogaine session

A properly run ibogaine treatment is a medical procedure, not an experience someone books like a retreat. In the hospital protocol behind the published Brazilian research — carried out in a licensed hospital, as São Paulo state’s drug-policy council recommends — the sequence is roughly this:

Before Screening comes first: an ECG, blood tests and a full clinical review, alongside a psychological evaluation. Patients dependent on cocaine or crack are asked to stop for four weeks beforehand, because both cocaine withdrawal and ibogaine itself slow the heart and prolong the QT interval — combining them raises cardiac risk unnecessarily. Opioid patients are switched from long-acting drugs such as methadone to a short-acting opioid, then treated once early withdrawal has begun, since ibogaine makes opioids more toxic and as little as possible should be circulating. Patients arrive on an empty stomach to reduce vomiting.

During Dosing is by body weight — in this protocol roughly 15 mg/kg for stimulant patients and 20 mg/kg for opioid patients, using pure ibogaine. Effects begin about an hour later. For most patients an introspective phase follows, often described as vivid autobiographical memories appearing in colour and slow motion when the eyes are closed; this phase eases after several hours. Physical withdrawal typically resolves early in the session. Patients remain under continuous monitoring in a private room, usually for 24 to 48 hours.

After Discharge is only when the patient is medically stable, accompanied, and with a day or two of rest planned. In this protocol, treatment is paired with roughly four psychotherapy sessions before and four after — and patients who decline psychotherapy are not accepted.

The ibogaine experience →

Is ibogaine a psychedelic? And does it contain DMT?

Ibogaine is psychoactive and produces a profound altered state, so it is often grouped with psychedelics — but it sits apart from them. Pharmacologically it acts on a much broader range of receptors than classic serotonergic psychedelics, and it has been classified variously as a hallucinogen, a psychedelic or an oneirogen, a “dream-inducer”, because the state it produces is closer to waking dreaming than to the visual intensity of psilocybin or LSD. Its duration is also far longer.

It does not contain DMT. Ibogaine and DMT are chemically distinct compounds from different plants, with different mechanisms and different clinical uses.

A more useful framing than any category comes from the programme behind the published research: there ibogaine is treated as a psychotherapy facilitator — the session opens the door, the therapy does the work.

Forms and purity

Two preparations are in common clinical use. Ibogaine hydrochloride (HCl) is the purified single alkaloid, and it is what most medical programs use, because a known quantity of one compound allows precise, weight-based dosing. Total alkaloid extract (TA) contains ibogaine alongside the other alkaloids naturally present in the plant.

Purity matters for safety, not for potency alone: dosing calculations assume you know what is in the bottle. Most pharmaceutical-grade ibogaine in circulation is above 90% purity, and there is an active push toward GMP-standard material above 99%.

Iboga vs ibogaine →

Risks, and who should not take ibogaine

Ibogaine’s principal danger is cardiac. It slows the heart rate and prolongs the QT interval, which in an unscreened patient — or one who has recently used stimulants, or is taking interacting medication — can lead to arrhythmia. Most of the deaths associated with ibogaine have occurred in unsupervised settings without screening, or involved other substances taken while ibogaine was still active in the body.

This is why the protocol, not the molecule alone, determines safety. In the hospital programme behind the published Brazilian research, safety is attributed directly to screening, the hospital setting and refusing patients who are not suitable.

Common contraindications include pre-existing cardiac conditions, psychiatric diagnoses such as psychosis or schizophrenia, certain liver problems, and medication combinations that must be resolved beforehand.

If a provider does not require an ECG and bloodwork, that is not convenience — it is the single clearest warning sign in this field.

Is ibogaine safe? → · Ibogaine side effects →

What the research shows

Ibogaine is not approved as a medicine in any country, and the clinical evidence base remains limited — largely because its legal status has made formal trials difficult to run.

The most relevant published work comes from Brazil. In a retrospective study co-authored by Dr. Rasmussen and published in the Journal of Psychopharmacology in 2014, 75 patients treated for alcohol, cannabis, cocaine and crack dependence were followed up. Of these, 61% were abstinent at follow-up; those treated once reported a median of 5.5 months of abstinence, and those treated more than once a median of 8.4 months — a statistically significant difference. No fatalities or serious adverse reactions occurred.

Two things are worth stating plainly. That cohort was non-opioid, so those specific figures should not be read as opioid outcomes. And a retrospective study is weaker evidence than a randomised trial — it describes what happened in one program, not what would happen everywhere.

Ibogaine research and evidence → · Ibogaine success rate →

Is ibogaine legal?

Legal status varies widely. Ibogaine is a controlled substance in the United States and restricted in much of Europe. In several other countries it is not banned, or is permitted under medical supervision — which is why treatment centres cluster in places such as Mexico and Brazil.

Brazil is a useful example of a legal grey area. Ibogaine is not on its controlled-substance lists, but it is not a registered medicine either; ANVISA, the national health regulator, says ibogaine treatments are not regulated and considers any commercial sale of the substance illegal. Clinics explain that they cannot hold stock — the medication is imported for each named patient, a process that takes around four weeks — and in 2016 São Paulo state’s drug-policy council recommended that treatment take place in a hospital.

Ibogaine legality by country →

Is ibogaine right for you?

Ibogaine is not a first-line treatment and not a guaranteed one. It is generally considered by people for whom conventional approaches — detox, rehab, maintenance medication — have not produced lasting results, and who are able and willing to travel, complete medical screening, and commit to the psychological work that follows.

Rehab Global is not a clinic and does not own clinics. If you want to know whether ibogaine treatment is a realistic option in your case, we will tell you honestly — including when the answer is no.

Ask about your options

Free and confidential. Our team reviews your case and replies within 24 hours.

Sources

  1. Schenberg EE, de Castro Comis MA, Chaves BR, da Silveira DX. Treating drug dependence with the aid of ibogaine: a retrospective study. Journal of Psychopharmacology. 2014;28(11):993–1000. doi:10.1177/0269881114552713

Frequently asked questions

01. What is ibogaine in simple terms?
A psychoactive alkaloid from the iboga plant, used in supervised medical settings to interrupt opioid withdrawal and reduce drug cravings.
02. What is ibogaine derived from?
The root bark of Tabernanthe iboga, and commercially also from Voacanga africana.
03. What does ibogaine do to the brain?
It converts in the liver to noribogaine; both act on multiple receptor systems including opioid receptors, which is why withdrawal stops.
04. Is ibogaine a psychedelic?
It is psychoactive but distinct from classic psychedelics — often classed as an oneirogen. It does not contain DMT.
05. How long does ibogaine last?
Effects begin about an hour after dosing; the acute phase runs around ten hours, with patients monitored 24–48 hours.
06. Is ibogaine dangerous?
Its main risk is cardiac. With ECG screening, bloodwork and continuous monitoring in a medical setting, that risk is managed — without them it is real.
07. Does ibogaine cure addiction?
No. It interrupts withdrawal and cravings, creating a window for psychotherapy and aftercare, which is where lasting recovery is built.

This article is for information only and is not medical advice. Ibogaine is not approved as a medicine in most countries and carries real risks. Treatment decisions should be made with qualified medical professionals.

Get a free, confidential assessment

Our consultation is free for you. Medical decisions are made by the clinic's doctors.